Page last updated: 2024-12-06

3,7-dinitrofluoranthene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID60018
CHEMBL ID353649
CHEBI ID82323
MeSH IDM0148065

Synonyms (18)

Synonym
ccris 2056
fluoranthene, 3,7-dinitro-
3,7-dinitrofluoranthene
hsdb 7089
fluoranthene, 3,7-dinitro
CHEMBL353649
chebi:82323 ,
3,7-dinitro-fluoranthene
C19234
105735-71-5
unii-14if3gwn26
14if3gwn26 ,
3,7-dinitrofluoranthene [hsdb]
3,7-dinitrofluoranthene [iarc]
dinitrofluoranthene, 3,7-
WAAHHGKGQYVTNS-UHFFFAOYSA-N
DTXSID20147305
Q27155875

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Results were reproducible, but without clear dose-response relationships."( Chromosomal aberrations induced in vitro by 3,7- and 3,9-dinitrofluoranthene.
Horikawa, K; Matsuoka, A; Sera, N; Sofuni, T; Tokiwa, H; Yamazaki, N, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nitronaphthaleneA nitroarene that is naphthalene substituted by at least one nitro group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (42.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]